Market›Health Care›Health Care Providers & Services›Health Care Services
INTERPACE BIOSCIENCE

IDXG

$1.98Jul 09, 2024 – Apr 24, 2026
Health CareHealth Care Providers & ServicesHealth Care Services$56M
MVM
+$0.6M
TD Variance
10.000

Every news event mapped to its market reaction — 23 events, 22 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-01-10-75.7%legalSEC EDGARIDXG 8-K: 8.01 and (SEC Filing)
2025-01-27+49.4%legalSEC EDGARIDXG 8-K: 2.05, 8.01 (SEC Filing)
2026-01-20+40.9%legalSEC EDGARIDXG 8-K: 2.02, 7.01 (SEC Filing)
2026-01-20+40.9%earningsmarketscreener.comInterpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure - marketscreener.com
2024-10-15+25.0%legalSEC EDGARIDXG 8-K: 1.01, 3.02, 3.03, 5.03, 7.01 (SEC Filing)
2025-05-09+22.4%earningsSeeking AlphaInterpace Biosciences GAAP EPS of $0.06, revenue of $11.5M
2024-08-02+22.3%earningsSeeking AlphaInterpace Biosciences GAAP EPS of $0.48, revenue of $12M
2024-08-02+22.3%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2024-11-04+21.0%earningsSeeking AlphaInterpace Biosciences GAAP EPS of $0.31, revenue of $12.3M
2025-03-31-18.4%earningsqz.comInterpace Biosciences Inc. (IDXG) reports earnings - qz.com
2025-05-08+12.2%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2025-11-12-11.8%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2025-05-01-10.3%legalSEC EDGARIDXG 8-K: 2.05, 8.01 (SEC Filing)
2026-03-30+9.9%newsGlobeNewswireInterpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results
2026-03-30+9.9%earningsSeeking AlphaInterpace Biosciences GAAP EPS of $0.82, revenue of $9.22M
2026-03-31+7.8%earningsInvesting.com CanadaInterpace Biosciences posts Q4 results, shares flat By Investing.com - Investing.com Canada
2025-12-03+6.9%legalSEC EDGARIDXG 8-K: 8.01 and (SEC Filing)
2024-11-06+5.4%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2025-08-08+3.4%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2026-04-01+2.8%legalSEC EDGARIDXG 8-K: 2.02 and (SEC Filing)
2025-01-21-2.6%legalSEC EDGARIDXG 8-K: 1.01, 2.03and2.05 (SEC Filing)
2025-08-07-1.9%earningsSeeking AlphaInterpace Biosciences GAAP EPS of -$0.14, revenue of $9.2M
2025-11-13-0.3%earningsSeeking AlphaInterpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
tickerdossier.comtickerdossier.substack.com